Sociedad Quimica y Minera S.A. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Sociedad Quimica y Minera S.A. Common Stock trades at $61.57 (market cap $17.95B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Sociedad Quimica y Minera S.A. Common Stock is far larger — about 10× Vir Biotechnology Inc. Common Stock's market cap, and Sociedad Quimica y Minera S.A. Common Stock pays a 3.86% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sociedad Quimica y Minera S.A. Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SQM | VIR | |
|---|---|---|
Market Cap | $17.95B | $1.80B |
Volume | 910,047 | 1,782,836 |
Sector | Basic Materials | Health |
52-Week High | $95.31 | $11.78 |
52-Week Low | $42.39 | $5.12 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $18.81B | $1.36B |
Dividend Yield | 3.86% | — |
Signals from Pluang's Aura AI — not financial advice
SQM trades at $62.83, up 0.58% today, but technical indicators signal a bearish trend with strong selling pressure. The company delivered mixed Q2 2026 earnings, beating EPS estimates with $2.31 vs. $2.03 expected, while Q1 and Q4 2025 missed expectations. Valuation metrics appear attractive with P/E of 12.93 and EV/EBITDA of 7.09, supported by strong profitability margins including 42.17% gross margin and 23.78% ROE.
Despite near-term technical weakness, SQM's fundamentals remain solid with projected revenue growth to $6.7B in 2026 and net profit margin expansion to 20.62%. The consensus price target of $92.50 suggests 47% upside potential, though lithium price volatility and recent earnings misses present execution risks. Analyst sentiment is mixed with 31% Buy ratings versus 19% Sell recommendations.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SQM is a mining and chemical company operating in northern Chile. Its businesses include lithium, iodine, specialty plant nutrition, potassium, solar salts, and industrial chemicals.
Read more on SQM →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →